Is Pelvic Health Physiotherapy Worth It? The Plain Trade-Off

Whether pelvic health physiotherapy is worth it depends on which condition you have, and this site will not average across them: for stress urinary incontinence in women it produced cure in 56% against 6% of untreated controls with high certainty, for prolapse it produced a modest symptom improvement, and for treating established incontinence after prostate surgery it produced no evidence of benefit at all. The cost side is equally uneven, and starts from an unusual fact: there is no official price for this treatment in any of the five health systems covered here¹².

I spent sixteen weeks on this and I would do it again, which is a conclusion rather than an argument, and my case is one of the ones where the evidence is strongest. Somebody reading this with a different condition should get a different answer, and a page that gave everybody mine would be worth less than nothing. Read red flags and when to stop and get checked first.

The benefit side, condition by condition

Four answers, in descending order of strength.

Stress urinary incontinence in women: the strongest case in the field. In a Cochrane review of 31 trials and 1,817 women comparing training against no treatment, placebo, sham or another inactive control, 56% were cured against 6% of controls, a risk ratio of 8.38 with a 95% confidence interval of 3.68 to 19.07, graded high certainty from 4 trials and 165 women. Cure or improvement was 74% against 11%, and leakage episodes fell by 1.23 per 24 hours¹. Three caveats travel with it every time: the high-certainty result rests on 165 women, quality of life was not pooled and is graded low certainty so no single effect size should be quoted, and the authors state that limited follow-up beyond the end of treatment leaves long term outcomes and cost-effectiveness uncertain.

Prevention around childbirth: one high-certainty finding, narrowly defined. Continent women who began antenatal training were about 29% less likely to report urinary incontinence at 3 to 6 months postpartum than those receiving usual care, 251 per 1,000 against 179 per 1,000, from 5 trials and 673 women, graded high certainty³. Started after birth as general prevention, or started as treatment in women already leaking, the same review does not show that benefit.

Prolapse: real and modest. The POPPY trial randomised 447 women with symptomatic stage I, II or III prolapse and found an adjusted difference of 1.52 points on a 0 to 28 symptom score at 12 months, with a 95% confidence interval of 0.46 to 2.59, and only 295 women, 66%, still in the trial at that point⁴. Good evidence of direction, modest evidence of magnitude, and no claim that anything is put back.

Established incontinence after radical prostatectomy: null. A Cochrane review of 50 trials and 4,717 men found no evidence from eight trials that training, with or without biofeedback, was better than control: 57% still incontinent against 62% of controls, a risk ratio of 0.85 with a 95% confidence interval of 0.60 to 1.22⁵. The authors concluded the evidence is conflicting and the value uncertain.

Read the complement of the best number as well as the number. 56% cured means 44% not cured, in the trial that produced the strongest result in this field. That is the honest denominator of the decision.

The time side, which is the larger cost for most people

Appointments are the smaller half.

The guideline minimum is at least 3 months of supervised training for stress or mixed urinary incontinence and at least 16 weeks, expressed elsewhere as at least 4 months, for symptomatic prolapse, with at least one review to assess progress during the programme and one at the end⁶⁷. Both durations derive from the same evidence and reflect the points at which trials measured results, so they are measurement windows rather than two prescriptions.

Between the appointments there is daily home work. NICE states a floor of at least 8 contractions performed 3 times per day, and that recommendation is tagged 2006 in NG123, meaning it was carried forward unchanged rather than re-reviewed in the 2019 update⁶. It is a minimum for a programme rather than a personal prescription, and a real one is set against an assessment: see pelvic floor exercise programmes explained.

The unglamorous version of that arithmetic is three short sessions a day for four months, most of them fitted around work, with nothing detectable happening for several weeks in the middle. In my case weeks 3 to 8 produced nothing I could measure, which is the stretch where people stop. How many sessions of pelvic health physiotherapy covers contact hours against home work, and sixteen weeks of exercises what it actually felt like is the week by week version.

The money side, starting with the finding that reframes it

There is no official price for pelvic health physiotherapy anywhere.

The Chartered Society of Physiotherapy states in its own position paper that competition law prevents it, in line with all other professional bodies, from seeking to negotiate rates for private practitioners². The American Physical Therapy Association publishes no US fee survey. The Australian Physiotherapy Association publishes no fee guidance. The Irish professional body publishes none. So every confident “average price” you find is a commercial survey or an aggregation of clinic price lists, and that is itself the useful finding.

What can be stated, by system:

• United Kingdom. Free at the point of use on the NHS, with the NHS itself noting there may be a long waiting list, and in many areas community musculoskeletal services reachable without a GP referral⁸. Privately, no pelvic-health-specific UK fee survey exists; the nearest general published figures come from the HMDG Private Practice Barometer 2026, an independent commercial survey of clinic owners fielded between August and November 2025, reporting a median of £74 for an initial appointment and £63 for a follow-up, with pelvic health typically at the upper end of clinic price lists.
• United States. Under Medicare Part B in 2026 the annual deductible is $283 with 20% coinsurance and no annual limit on medically necessary outpatient therapy⁹. The Medicare-approved amount for the pelvic-floor-specific biofeedback code is roughly $82 for the first 15 minutes, so a beneficiary’s share is around $17 to $20 per visit once the deductible is met. The old therapy cap was repealed in 2018 and replaced by a $2,480 threshold requiring a modifier and a separate $3,000 targeted review threshold, so “Medicare caps physical therapy” is false. Cash rates outside insurance have no authoritative source.
• Australia. No pelvic health item exists in the Medicare Benefits Schedule at all. Access is through the generic allied health item 10960, schedule fee A$74.55 with an 85% benefit of A$63.40 for a minimum 20 minute service¹⁰. The cap is five allied health services per calendar year shared across every allied health profession, not five physiotherapy sessions, and the programme was renamed a GP Chronic Condition Management Plan on 1 July 2025. Regulator data for the quarter ending March 2026, covering 3.2 million physiotherapy services, gives an average fee charged of A$103.35, an average benefit of A$44.46 and an average out-of-pocket cost of A$58.90 per service, across all physiotherapy rather than pelvic health specifically¹¹.
• Canada. Provincial insurance largely does not cover outpatient physiotherapy. British Columbia contributes $23 per visit up to a combined annual limit of 10 visits shared across six therapy types, income-tested below an adjusted net income of $42,000¹². The only Canadian association fee guidance with a pelvic health line quotes $63.00 to $78.00 per 15 minute unit for pelvic health, explicitly non-binding, while the same document states the current average rate for in-person treatment across the province is $98.11 per 30 minutes, which does not reconcile with its own per-unit rates. Both are quoted rather than averaged.
• Ireland. Public physiotherapy requires a referral from a GP, public health nurse or hospital, though Citizens Information also states that you can refer yourself, and notes that HSE community physiotherapy is not available in all areas; medical card holders may be prioritised for free treatment¹³. No official Irish private fee figure exists, and whether pelvic health physiotherapy specifically is available in the HSE public system could not be confirmed from any published source, so this site does not assert that it is.

How much does pelvic health physiotherapy cost works through the per-course arithmetic in each system.

The cost nobody prices: waiting

Where treatment is free, the price is time, and the data on that are mostly absent.

No published national waiting time for pelvic health physiotherapy exists in England, Ireland, Australia or Canada. NHS England’s community waiting list collection publishes banded counts rather than a median, and pelvic health is not a service line within it at all. Perinatal pelvic health services publish no access data whatsoever. Ireland is the only one of the five with a genuine published national physiotherapy statistic, and it covers all primary care physiotherapy with no pelvic health breakdown.

This site does not substitute a musculoskeletal waiting figure for a pelvic health one, because a reader on a pelvic health list is not in the musculoskeletal queue. Pelvic health physiotherapy waiting times is written around that absence, and getting referred to pelvic health physiotherapy covers the routes, including where self-referral exists.

Does the benefit last long enough to justify the outlay

Better than the adherence figures make you fear.

Across 19 studies following 1,141 women for between 1 and 15 years, long term adherence varied between 10% and 70%, long term success among the original responders varied between 41% and 85%, and surgery rates at long term follow-up varied between 4.9% and 58%. The authors concluded that short term outcomes could be maintained at long term follow-up without incentives for continued training¹⁴.

Most people stop doing the full programme. The benefit does not fall as far as that implies. Both halves belong in a decision about whether four months is worth spending, and keeping it up after discharge covers what maintenance realistically looks like.

Who it is probably not worth it for, stated plainly

Three groups, and no site that wanted your booking would list them.

People whose pelvic floor is overactive and who are offered a strengthening programme. For that presentation conventional strengthening addresses the wrong failure and can make symptoms worse, so the value is negative until the direction is corrected: see hypertonic pelvic floor and downtraining.

Men seeking treatment for established incontinence after prostate surgery, if the expectation is cure. The treatment analysis is null⁵. That does not mean nothing is worth doing, and men’s pelvic health after prostate surgery sets out what remains, but expectations should be set from the null result rather than from the female incontinence figures.

Anyone offered an unsupervised, unreviewed course and told it is the same thing. It is not what the trials tested, and NICE’s own wording specifies supervision and two reviews⁷.

The decision, framed honestly

The pathway is sequenced so that this comes first: NICE offers surgery for prolapse to women whose symptoms have not improved with non-surgical treatment or who have declined it⁶. So the real choice is between spending three to four months finding out, and declining and having the next conversation now, and both are legitimate.

My own summary, offered as one case rather than as evidence: sixteen weeks bought back the club run and the drawer of clothes I had stopped wearing, and did not cure me. Whether that trade is worth four months of daily work is a question about your life, not about the literature. Pelvic floor physiotherapy sets out the treatment in full, and when physiotherapy is not enough covers what happens if you spend the four months and it does not deliver.